Rhythm Pharmaceuticals Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 298.09, 539.24, 866.48, 1291.36, 1790.56 ], "ebit_estimate": [ -205.54, -45.82, 245.26, 477.2, 850.58 ], "ebitda_estimate": [ -207.53, -69.57, 189.81, null, null ], "net_income_estimate": [ -215.18, -48.07, 229.81, 533.54, 886.27 ], "per_share_eps_estimate": [ -3.2, -0.64, 2.83, 6.7, 10.95 ], "eps_nri_estimate": [ -3.19, -0.7, 2.99, 7.34, 10.95 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 9.04, 19.48, 26.81, null, null ], "pretax_income_estimate": [ -207.26, -48.7, 245.07, 601.1, 1042.4 ], "operating_cash_flow_per_share_estimate": [ 3.44, 7.7, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -164.91, -95.14, 19.19, null, null ], "gross_margin_estimate": [ 90.17, 89.77, 90.17, 90.5, 90.5 ], "operating_cash_flow_estimate": [ 233.83, 523.4, null, null, null ], "pettm_estimate": [ 0, 0, 38.36, 16.18, 9.9 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "67.34", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 67.34, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 132.83, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 67.53, 79, 93.5, 100.89, 127.15, 149.45, 175.63 ], "ebit_estimate": [ -52.58, -51.23, -46.05, -46.28, -19, 5, 11 ], "ebitda_estimate": [ -53.38, -52.36, -51.51, -46.41, null, null, null ], "net_income_estimate": [ -55.57, -54.11, -52.68, -53.81, -17, 7, 14 ], "per_share_eps_estimate": [ -0.83, -0.81, -0.78, -0.65, -0.32, -0.04, 0.28 ], "eps_nri_estimate": [ -0.83, -0.8, -0.76, -0.69, -0.32, -0.04, 0.28 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -53.98, -51.18, -48.47, -47.51, -20.7, 1.65, 9.65 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -109.51, -124.92, -147.45, -223.04, null, null, null ], "gross_margin_estimate": [ 89.87, 90.43, 90.73, 92, 92, 92, 87 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "67.34", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 67.34, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 132.83, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }